Journal List > Tuberc Respir Dis > v.62(2) > 1001054

TOOLS
Jung, Lee, Kim, Ahn, and Chang: A Case of Subungal Abscess and Onycholysis Induced by Docetaxel
Case Report
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2007; 62(2): 125-128.

Published online: 28 February 2007

DOI: https://doi.org/10.4046/trd.2007.62.2.125

A Case of Subungal Abscess and Onycholysis Induced by Docetaxel

Han Young Jung, M.D.1, Chang Youl Lee, M.D.1, Hyung Jung Kim, M.D.1, 2, Chul Min Ahn, M.D.1, 2, Yoon Soo Chang, M.D.1

1Department of Internal Medicine, The Yonsei University College of Medicine, Seoul, Korea.

2Institute of Chest Diseases, The Yonsei University College of Medicine, Seoul, Korea.

Address for correspondence: Yoon Soo Chang, M.D. Department of Internal Medicine, 8th Floor Annex Building Yongdong Severance Hospital, 146-92 Dogok-dong, Kangnam-gu, Seoul 135-270, Korea. Tel: 02-2019-3309, Fax: 02-3463-3882, yschang@yumc.yonsei.ac.kr

Received 11 December 2006       Accepted 8 February 2007

Copyright © 2007 The Korean Academy of Tuberculosis and Respiratory Diseases

Abstract

Docetaxel is a taxoid antineoplastic drug, which is widely used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC). Among the adverse dermatological reactions, nail disorders such as bending, onycholysis, hypo- or hyperpigmentation are rare. We report a case of a 62-year-old male with advanced NSCLC (cT4N3M1, stage IV), who developed purulent discharge and onycholysis in the nail of all his fingers and the left great toe after five courses of anti-neoplastic chemotherapy, which included docetaxel (cumulative dose: 370 mg/m2, 590 mg). Seven days after the final session of chemotherapy, the patient had become aware of discoloration and swelling of the nail beds with out pain. Three days later, greenish-yellow purulent discharge oozed out from the involved nails. Microbiologic studies revealed Pseudomonas aeruginosa. Intravenous and topical antibiotics (mupirocin) were applied. After 2 weeks, regrown nails were observed and the onycholysis had improved.

Keywords: Docetaxel, Onycholysis, Subungal abscess

Figures and Tables

Figure 1
Computed tomography shows mass lesion in the lower lobe of left lung
trd-62-125-g001
Figure 2
After 5th chemotherapy, computed tomography shows marked resolution of primary tumor in the ekf
trd-62-125-g002
Figure 3
At initial admission, all finger nails showed subungal abscess and onycholysis induced by docetaxel.
trd-62-125-g003
Figure 4
All finger nails showed improvement after 14-days antibiotic treatment.
trd-62-125-g004

References

1. Miller VA, Krug LM, Ng KK, Pizzo B, Perez W, Heelan RT, et al. Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2000. 18:1346–1350.
2. Janinis J, Papadakou M, Panagos G, Panousaki A, Georgoulias V, Hatzidaki D, et al. Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. Am J Clin Oncol. 2001. 24:227–231.
3. Tinio P, Bershad S, Levitt JO. Docetaxel-induced onycholysis. J Am Acad Dermatol. 2005. 52:350–351.
4. Obermair A, Binder M, Barrada M, Bancher-Todesca D, Asseryanis E, Kubista E. Onycholysis in patients treated with docetaxel. Ann Oncol. 1998. 9:230–231.
5. Almagro M, Pozo JD, Garcia J, Vasquez A, Fonseca E. Nail alterations secondary to paclitaxel therapy. Eur J Dermatol. 2000. 10:146–147.
6. Moisidis C, Mobus V. Erythema multiforme major following docetaxel. Arch Gynecol Obstet. 2005. 271:267–269.
7. Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, et al. Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol. 2003. 14:333–337.
8. Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J. Nail changes secondary to docetaxel (Taxotere). Dermatology. 1999. 198:288–290.
9. Vanhooteghem O, Andre J, Vindevoghel A, Vandenbossche L, Vandeveire A, Song M. Docetaxel-induced subungal hemorrhage. Dermatology. 1997. 194:419–420.
10. Lee MS, Kim HO, Park YM. A case of subungal abscess and onycholysis related to docetaxel. Korean J Dermatol. 2003. 41:1393–1395.
11. Nicolopoulos J, Howard A. Docetaxel-induced nail dystrophy. Australas J Dermatol. 2002. 43:293–296.
12. Wasner G, Hilpert F, Schattschneider J, Binder A, Pfisterer J, Baron R. Docetaxel-induced nail changes: a neurogenic mechanism: a case report. J Neurooncol. 2002. 58:167–174.
13. Jones R, Ryan M, Friedlander M. Carboplatin hypersensitivity reactions: retreatment with cisplatin desensitisation. Gynecol Oncol. 2003. 89:112–115.
14. Scotte F, Tourani JM, Banu E, Peyromaure M, Levy E, Marsan S, et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol. 2005. 23:4424–4429.
TOOLS
Similar articles